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ABSTRACT 
 
In this paper, a study examining high-risk situations for relapse is 
presented. The sample consisted of 72 participants (51 male and 21 female) 
who had relapsed after having received a residential psychological treatment 
for drug addition in a therapeutic community in Spain. In order to analyze 
what personal, environmental or social factors were the most immediate 
triggers of relapse, a personal interview, using the Relapse Interview, was 
administered to each one of the relapsed patients. Results showed that 
most of the relapses took place during the first year after completing the 
treatment program. Likewise, the factors most frequently cited for relapse 
were the following: to cope with negative emotional states (49.5%), to be 
unable to resist temptations or impulses to consume (17.5%), to test 
personal control (10.3%) and to cope with interpersonal conflicts (9.3%). 
As can been observed, most factors were of an intrapersonal nature. 
Implications of these results for further research and clinical practice are 
commented upon. 
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INTRODUCTION 
Relapses are a serious and persistent problem in the treatment of 
drug use disorders (1). In fact, relapse is one of the most common 
outcomes following initiation of drug abstinence. Related to this factor, 
substance abuse disorders have long been recognized as chronic relapsing 
conditions. Considering the high cost of medical care involved in one 
addiction detoxification and treatment process, treatment repetition 
continues to be a major concern to all involved (2).  
Over the past decades, cognitive-behavioral research on addiction 
relapse has documented the harmful impact of postreatment environment 
for addiction recovery. In this sense, the model for relapse prevention 
proposed by Marlatt & Gordon (3) is perhaps the most prominent model for 
addiction relapse to emerge in the past 30 years. A central construct in this 
model is the “high-risk situation” for relapse. Relapse prevention model 
seeks to identify high-risk situations in which an individual is vulnerable to 
relapse and to use both cognitive and behavioral coping strategies to 
prevent future relapses in similar situations (4). 
In order to identify the main immediate precipitants of relapses 
during addiction abstinence, systematic research on this problem has been 
developed in the last years (5-13). However, Marlatt & Gordon (3) used a 
“hierarchical” method of coding in which only one main precipitant was 
coded for each relapse. However, such procedures for measurement may 
have oversimplified the concept of a high-risk situation, since some 
research suggests that high-risk situations may often involve more than one 
factor (8, 14). 
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The present study examined relapse determinants reported by 
patients treated for drug dependence in a residential setting. The major 
purpose of this study was to provide descriptive data on the first relapse 
episodes and the specific relapse determinants according to the relapse 
taxonomy of Marlatt & Gordon (3).  
METHOD 
Participants 
 The sample for this study consisted of 72 participants (51 male and 21 
female) who had relapsed after having received psychological treatment for 
drug addition in a therapeutic community in Spain (Proyecto Hombre de 
Navarra). This is a drug-free program with a total of 30 months of duration. 
 Those selected for the sample were required to: a) be an adult person 
(between 18 and 65 years old); b) have received a drug-free psychological 
treatment in the Proyecto Hombre de Navarra Therapeutic Community; c) 
have maintained drug abstinence for at least 6 months (in order to properly 
consider it as a long-term relapse); and d) have experimented a relapse after 
this period of abstinence. All participants took part voluntarily in the study, 
after having been properly informed of its characteristics. 
 Regarding the main sociodemographical characteristics of the selected 
sample, the mean age was 27.4 (SD=4.1). Most of them (57 patients) were 
single (79.2% of the total sample) and with a low education level (only 7 
patients had secondary studies or more). On the other hand, the main drug 
dependence problem was related to the following: heroin (57; 79.2%), 
cocaine (7; 9.7%), heroin + cocaine (5; 6.9%), and others (3; 4.2%).   
Assessment measures 
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 In order to facilitate the collection of information about patients, a 
personal interview was administered to each one of the relapsed patients, 
with the following assessment tools: 
The Structured Clinical Interview (not published) is an instrument designed to 
assess sociodemographical and drug use variables in addicted patients.  
The Relapse Interview (15) is an instrument that allows the analysis of what 
personal, environmental or social factors are the most immediate 
precipitants of relapse. Therefore, this interview helps to identify high-risk 
situations for relapse and it is useful for relapse prevention programs. 
Briefly, it is composed of two big categories: intrapersonal and interpersonal 
determinants of relapse. 
Procedure 
 Patients of this study form part of a wider research carried out about 
the effectiveness of the Proyecto Hombre de Navarra Therapeutic 
Community. All patients were interviewed during the follow-up period 
(mean time of 6 years after leaving treatment) and when a relapse had 
taken place, a detailed retrospective personal interview was made with each 
one of them in order to identify factors that immediately precede relapse 
episodes. In this study, relapse was defined as three consumptions in 
separate days of an illegal drug during a period of two consecutive months. 
The rationale for defining relapse according to this criterion is that it has 
been used in the only previous study carried out in Spain (16, 17). It makes 
possible the comparison between results. 
 In order to provide an evaluation of a more complex concept of high-
risk situation, in this study patients were not restricted in the number of 
relapse precipitants they reported. Participants were free to report more 
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than one precipitant for a given relapse episode. Once precipitants were 
reported, they were coded according to the 17 categories described in 
Marlatt, Stout, Zywiak & the Relapse Research Group (18).  
The interviews were carried out by a trained clinical psychologist. No 
monetary incentive was offered for participation in the study and all 
patients gave their informed consent to participate in the study. 
RESULTS 
Time to first relapse 
 Relapses lasted an average of 23.5 months (SD: 22.4; range: 1-96 
months). Data related to the specific moment of relapse are presented in 
table 1.  
------------------------------------------------------------------------------------- 
PLACE TABLE 1 HERE 
------------------------------------------------------------------------------------- 
 
 Most of the relapses took place during the first year after completing 
the treatment program. Thus, half of the studied patients (52.8% of them) 
had relapsed during this period. Furthermore, 77.8% of the relapses had 
taken place during the 2 years after finishing the treatment. Relapses starting 
after the 2 years were scarce in the studied sample. 
On the other hand, most of the relapses involved the use of cannabis 
(37.4%), followed by cocaine (31.6%), heroin (18.7%) and 
benzodiazepines (15.5%).  
Determinants of relapse 
 A total of 97 determinants of relapse were referred by the 72 
participants of this study (an average of 1.34 determinants per patient; a 
maximum of three categories reported by a subject). Most of them were 
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intrapersonal precipitants (82.5% of the total) and only 17.5% were 
interpersonal determinants of relapse. 
Intrapersonal determinants of relapse 
 The relapse determinant of an intrapersonal nature most frequently 
reported by subjects was to cope with negative emotional states (49.5%) 
(table 2). The next most frequent choices were to be unable to resist the 
temptations or impulses to consume (craving) (17.5%), to test personal 
control (10.3%), to cope with negative physical conditions (3.1%) and to 
optimize positive emotional states (2.1%).  
------------------------------------------------------------------------------------- 
PLACE TABLE 2 HERE 
------------------------------------------------------------------------------------- 
 
Interpersonal determinants of relapse 
 Related to interpersonal relapse determinants, the most frequently 
endorsed by patients was to cope with interpersonal conflicts (9.3%), 
followed by to optimize positive mood states (6.2%) and social pressure 
(2.1%). 
DISCUSSION 
 This is an exploratory and descriptive study about reasons that 
precipitate relapses in addicted patients after completing a drug-free 
therapeutic community treatment program. The study of high-risk factors 
for relapse is important in order to implement relapse prevention programs 
following Marlatt and Gordon’s (3) cognitive-behavioral model of relapse.  
However, there are not many studies on this topic in a Therapeutic 
Community setting. This is an important feature because the study of 
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aftercare has been shown as an important factor for relapse prevention 
(19). 
 The strong points of this study reside in several important features. 
First, this research has studied relapses during a long-time follow-up period 
(mean time of 6 years after leaving treatment). Most of the studies 
published about relapse precipitants take into account a shorter period of 
follow-up (mainly, 1 year). Second, this study is based on reports by 
patients about their own relapse episodes. Third, patients were not 
restricted in the number of relapse precipitants they reported, in order to 
provide an evaluation of a more complex concept of high-risk situations. 
Thus, participants were free to report more than one precipitant for a given 
relapse episode. 
Results showed that most of the relapses took place during the first 
years of abstinence. To be specific, 77.8% of the relapses had taken place 
during the 2 years after finishing the treatment, and the average time for the 
first relapse was 23.5 months. These results are similar to those obtained in 
other previous studies (9, 11, 17). Therefore, the first follow-up months, once 
the treatment is completed, are a high-risk moment for relapse. Thus, the 
implementation of relapse prevention programs after finishing the treatment 
is important for the maintenance of drug abstinence for a long-time.   
On the other hand, in this study participants reported a large 
heterogeneity of relapse determinants. The most frequently cited factors for 
relapse were the following: to cope with negative emotional states (49.5%), 
to be unable to resist the temptations or impulses to consume (craving) 
(17.5%), to test personal control (10.3%) and to cope with interpersonal 
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conflicts (9.3%). This distribution of determinants is similar to that obtained 
in other studies (11, 13, 17, 20). 
Therefore, multiple factors contributed for relapse events. As 
occurred in other studies (8, 11), these data suggest that individuals who 
relapse often perceive the episode to be due to the occurrence of a 
combination of high-risk situations. Nevertheless, participants most 
consistently reported relapse determinants of an intrapersonal nature. 
These results are consistent with both Marlatt and Gordon’s (3) initial 
research and more recent studies on factors triggering relapse episodes 
following addiction treatment (6, 9, 11, 13). 
Regarding intrapersonal precipitants of relapses, the most relevant 
one found in this study is related to coping with negative emotional states.  
However, patients had many problems to identify specific emotional states 
(for example, frustration, anger, anxiety or depression) and they tended to 
report general emotional states (less strong but more elongate). Anyway, 
the link between negative affects and relapse has been highlighted by a 
number of previous studies (7, 8, 11, 21). Moreover, negative affect has 
recently been identified as the primary motive for both drug use (22) and 
alcohol consumption (13). These last results could be consistent with an 
affective model of drug motivation (the self-medication model of 
dependence). 
Any case, emotional states become a nuclear aspect to be 
contemplated in any relapse prevention program. An emotional alteration 
hinders patient's rational behavior, and it shrinks the capacity for the 
development of effective coping strategies in dealing with high-risk 
situations. Patients, in this kind of situations, remember the short-term 
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positive consequences of the addictive behavior, and the probability of 
being implied in drug consumption, as a way of liberating tension (an 
erroneous form of self-treatment), is increased. Therefore, an important 
aspect of relapse prevention programs is to contemplate the learning of 
strategies for coping with adverse emotional states: communications 
abilities, problem solving techniques, relaxation, implementation of free-
time activities, etc. 
 The second factor which is the choice by patients as a precipitant of 
relapse is craving (17.5%). This is possibly the most widely studied and the 
most poorly understood concept in the study of drug addiction (3, 21). 
Siegel, Krank & Hinson (24) proposed that both craving and symptoms of 
withdrawal may act as conditioned drug-compensatory responses, which are 
often in the opposite direction from the actual unconditioned drug effect. 
These responses are conditioned by exposure to several drug-related stimuli 
paired with physiological effects of the drug. Often referred as tolerance, 
this process is explained by environmental drug cues eliciting a preparatory 
physiological response to prepare the individual for the drug effects. The 
preparatory response allows the individual to consume more of a desired 
substance while reducing the effects of the drug (25). More recently, 
craving has been broadly defined by conditioned reinforcement models (26), 
incentive-sensitization models (27), dopamine system regulation (28), 
social learning theory (29), and cognitive processing models (30). In any 
case, in this study craving is mainly produced in presence of cues 
associated to the drugs (16.5%), and only in one case craving appeared 
without the presence of cues associated to the drugs.  
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 Nevertheless, the association between subjective reports of craving 
and relapse still remains unclear. While some studies have found a strong 
association between craving and relapse (6), others have highlighted the 
lack of a strong association (30, 31). These disappointing results are 
probably related to the larger problem of measuring this phenomenon (32, 
33). 
 However, factors of importance in other researches are not relevant 
in this study. For example, in the sample studied, social pressure is only 
implicated in the relapse of two patients (2.1%), and both cases are related 
to an indirect social pressure. However, negative social support in the form 
of interpersonal conflicts is implied in the 10.3% of the cases. 
In any case, there are some limitations in this study. First, this is an 
exploratory and descriptive study in which the sample is probably not large 
enough. Second, as this study was conducted among patients treated in a 
residential setting, the results cannot be generalized to a community 
sample. Third, as in other studies (9), relapse appears as static process, 
whereas it is fairly well established that the process of dynamic interaction 
between the individuals and the environment modulates the relapse. 
Fourth, in this study a retrospective approach has been use to identify 
relapse precipitants. However, a prospective assessment provides an 
opportunity to measure possible precipitants in near real time sometime 
prior to exposure to a high-risk situation (34). Anyway, in this study there 
was a long lag between the beginning of the relapse and the relapse 
interview. As it has been suggested by other authors (35), this approach 
has serious limitations, including the possibility of a retrospective bias (for 
example, the occurrence of the relapse itself biases later explanations about 
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it happened or a general decay in the accuracy of memories over time). 
Finally, it is important to highlight that relapse precipitants are only one 
part of the relapse process. That what a patient does in a high-risk situation 
is more important than the specific nature of the high-risk situation. 
Nevertheless, the results obtained suggest a number of specific ways that 
drug treatment can be tailored, as, for example, including specific 
interventions in the treatment guides in order to teach patients how to deal 
with the high-risk situations identified.  
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TABLE 1 
MOMENT OF THE FIRST RELAPSE 
 
 
Years 
 
N            (%) 
Accumulated 
frequency 
N            (%) 
 1 year 
1 month 
3 months 
6 months 
12 months 
 38        (52.8%) 
         8        (11.1%) 
         5          (6.9%) 
       15         (20.8%) 
       10         (13.9%) 
  38        (52.8%) 
         8        (11.1%) 
       13        (18.1%) 
       28        (38.9%) 
       38        (52.8%) 
2 years 
18 months 
24 months 
 18        (25%)            
         4          (5.6%) 
       14        (19.4%) 
  56        (77.8%)    
       42        (58.3%) 
       56        (77.8%) 
3 years     8          (11.1%)   64        (88.9%) 
4 years     6            (8.3%)   70        (97.2%) 
5 years     0   70        (97.2%) 
6 years     2            (2.8%)   72      (100.0%) 
TOTAL   72        (100%)   72      (100%) 
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TABLE 2 
DETERMINANTS OF RELAPSES (N=97) 
 
I) INTRAPERSONAL DETERMINANTS  N      (%) 
A) To cope with negative emotional states     48  (49.5%) 
1) To cope with frustration/anger 
2) To cope with depression 
3) To cope with anxiety 
4) To cope with other negative emotional states 
      5    (5.2%) 
      0 
      0 
    43 (44.3%) 
B) To cope with negative physical conditions       3  (3.1%) 
1) To cope with physical conditions associated to 
previous consumption 
2) To cope with others physical conditions 
 
      1 (1.1%) 
      2 (2.1%) 
C) To optimize positive emotional states       2  (2.1%) 
D) To test personal control     10  (10.3%) 
E) To be unable to resist the temptations or impulses     17  (17.5%) 
1) In presence of cues associated to the drugs 
2) Without presence of cues associated to the drugs 
    16 (16.5%) 
      1 (1.1%) 
TOTAL INTRAPERSONAL DETERMINANTS    80  (82.5%) 
II) INTERPERSONAL DETERMINANTS  N      (%) 
A) To cope with interpersonal conflicts      9  (9.3%) 
1) To cope with frustration/anger 
2) To cope with depression 
3) To cope with anxiety 
4) To cope with other negative emotional states 
     0 
     0 
     0 
     9 (9.3%) 
B) Social pressure     2  (2.1%) 
1) Direct social pressure 
2) Indirect social pressure 
    0 
    2 (2.1%) 
C) To optimize positive mood states    6  (6.2%) 
TOTAL INTERPERSONAL DETERMINANTS     17  (17.5%) 
  
 
  
